Suzhou Kuntai Biotechnology Co., Ltd., with a registered capital of 30 million yuan, is located in Suzhou Industrial Park Biomedical Industrial Park, and its business address is located in Building 21, Ascendas Innovation Park, No. 388, Xinping Street, is a growth company engaged in independent research and development of characteristic APIs, Sino-US registration and application, production and global sales integration, and is a wholly-owned subsidiary of Fujirai (stock code: 301258). The company closely follows the cutting-edge technology of medicine, and establishes an independent technology research and development platform based on the development trend of the biomedical industry. The company is committed to providing cGMP-compliant small molecule characteristic APIs and pharmaceutical intermediates for domestic and foreign customers, while developing and strategically deploying the field of oligonucleotide drugs to provide customers with personalized customized synthesis and production services.